CoChat

Tumor characteristics associated with engraftment of patient‐derived non–small cell lung cancer xenografts in immunocompromised mice

Open access
Chen, Yungchang, Zhang, Ran, Wang, Li, Correa, Arlene M., Pataer, Apar, Xu, Yi, Zhang, Xiaoshan, Ren, Chenghui, Wu, Shuhong, Meng, Qing H., Fujimoto, Junya, Jensen, Vanessa B., Antonoff, Mara B., Hofstetter, Wayne L., Mehran, Reza J., Pisimisis, George, Rice, David C., Sepesi, Boris, Vaporciyan, Ara A., Walsh, Garrett L., Swisher, Stephen G., Roth, Jack A., Heymach, John V., Fang, Bingliang · 2019 · Cancer
Cited by 42

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background: Patient‐derived xenograft (PDX) models increasingly are used in translational research. However, the engraftment rates of patient tumor samples in immunodeficient mice to PDX models vary greatly. Methods: Tumor tissue samples from 308 patients with non–small cell lung cancer were implanted in immunodeficient mice. The patients were followed for 1.5 to approximately 6 years. The authors performed histological analysis of PDXs and some residual tumor tissues in mice with failed PDX growth at 1 year after implantation. Quantitative polymerase chain reaction and enzyme‐linked immunoadsorbent assay were performed to measure the levels of Epstein‐Barr virus genes and human immunoglobulin G in PDX samples. Patient characteristics were compared for PDX growth and overall survival as outcomes using Cox regression analyses. Disease staging was based on the 7th TNM staging system. Results: The overall engraftment rate for PDXs from patients with non–small cell lung cancer was 34%. Squamous cell carcinomas had a higher engraftment rate (53%) compared with adenocarcinomas. Tumor samples from patients with stage II and stage III disease and from larger tumors were found to have relatively high engraftment rates. Patients whose tumors successfully engrafted had worse overall survival, particularly those individuals with adenocarcinoma, stage III or stage IV disease, and moderately differentiated tumors. Lymphoma formation was one of the factors associated with engraftment failure. Human CD8‐positive and CD20‐positive cells were detected in residual samples of tumor tissue that failed to generate a PDX at 1 year after implantation. Human immunoglobulin G was detected in the plasma of mice that did not have PDX growth at 14 months after implantation. Conclusions: The results of the current study indicate that the characteristics of cancer cells and the tumor immune microenvironment in primary tumors both can affect engraftment of a primary tumor sample.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.32366

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 42

Metadata

Authors
Chen, Y., Zhang, R., Wang, L., Correa, A. M., Pataer, A., Xu, Y., Zhang, X., Ren, C., Wu, S., Meng, Q. H., Fujimoto, J., Jensen, V. B., Antonoff, M. B., Hofstetter, W. L., Mehran, R. J., Pisimisis, G., Rice, D. C., Sepesi, B., Vaporciyan, A. A., Walsh, G. L., Swisher, S. G., Roth, J. A., Heymach, J. V., & Fang, B.
Venue
Cancer
Publisher
Wiley
Published
2019-07-09
Volume
125
Issue
21
Pages
3738-3748
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2962598835
Cited by
42
References
2
FWCI
2.09
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor characteristics associated with engraftment of patient‐derived non–small cell lung cancer xenografts in immunocompromised mice. https://app.cochat.ai/papers/10.1002/cncr.32366
The paper
Chen, Y., Zhang, R., Wang, L., Correa, A. M., Pataer, A., Xu, Y., Zhang, X., Ren, C., Wu, S., Meng, Q. H., Fujimoto, J., Jensen, V. B., Antonoff, M. B., Hofstetter, W. L., Mehran, R. J., Pisimisis, G., Rice, D. C., Sepesi, B., Vaporciyan, A. A., . . . Fang, B. (2019). Tumor characteristics associated with engraftment of patient‐derived non–small cell lung cancer xenografts in immunocompromised mice. Cancer. https://doi.org/10.1002/cncr.32366

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.